Loading...
XSHE
300760
Market cap34bUSD
Dec 05, Last price  
202.39CNY
1D
1.20%
1Q
-14.95%
IPO
161.82%
Name

Shenzhen Mindray Bio-Medical Electronics Co Ltd

Chart & Performance

D1W1MN
XSHE:300760 chart
P/E
21.01
P/S
6.67
EPS
9.63
Div Yield, %
2.78%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
17.27%
Revenues
36.73b
+5.14%
7,835,717,6008,013,109,7269,031,723,19411,173,795,36413,753,357,46916,555,991,31421,025,846,38925,269,580,81830,365,643,81134,931,900,88436,725,750,000
Net income
11.67b
+0.74%
1,359,671,100909,879,6321,600,457,0162,589,154,7513,719,236,1694,680,646,7506,657,676,0628,001,553,6069,607,174,09411,582,226,08511,668,487,000
CFO
12.43b
+12.38%
1,741,478,7002,023,902,7073,039,526,4873,300,366,9194,034,585,3764,721,794,9158,870,109,8498,998,649,17512,141,147,87611,062,025,29512,432,041,281
Dividend
Sep 09, 20244.06 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.
IPO date
Oct 16, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT